PREPARATIONS CONTAINING AMORPHOUS EMODEPSIDE
The invention relates to preparations comprising amorphous emodepside in a polyvinylpyrrolidone matrix, pharmaceuticals comprising such preparations, and their use against endoparasites in animals or humans.
1 . (canceled)
2 . (canceled)
3 . (canceled)
4 . (canceled)
5 . (canceled)
6 . (canceled)
7 . (canceled)
8 . (canceled)
9 . (canceled)
10 . (canceled)
11 . A method for treating or preventing an endoparasite comprising administering to a human or animal in need thereof an effective amount of a pharmaceutical composition comprising emodepside in a polyvinylpyrrolidone matrix, wherein at least 50% of the emodepside is in an amorphous form.
12 . The method according to claim 11 , wherein the endoparasite is a helminth selected from Platyhelmintha, Nematoda, Pentastoma and Acanthocephala.
13 . The method according to claim 12 , wherein the Platyhelmintha is selected from Monogenea, Cestoda and Trematoda.